Trial Profile
Bioeqivalence study of new procaterol hydrochloride hydrate dry powder inhaler and the approved dry powder inhaler in patients with asthma: A randomised, double-blind phase III study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Sep 2017
Price :
$35
*
At a glance
- Drugs Procaterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 20 Sep 2017 New trial record
- 01 Jan 2017 Primary endpoint of maximum FEV1 during the 480-minute measurement period has been met, according to results published in the Clinical Pharmacology in Drug Development.
- 01 Jan 2017 Primary endpoint of area under the concentration-time curve (AUC) (FEV1)/h has been met, according to results published in the Clinical Pharmacology in Drug Development